SEC Form 4 · accession 0001140361-16-088922
CYTRX CORP · CYTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Earl W Brien
Director
Period of report
Dec 2, 2016
Accepted (ET)
Dec 6, 2016 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000799698
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1,F2 | $0.52 | Dec 2, 2016 | A | 180,000 | A | Dec 2, 2016 | Dec 1, 2026 | CytRx Common Stock | 180,000 | 180,000 | D |
Explanation of responses
- F1Initial grant of stock options upon joining the CytRx Board of Directors as a Class III director.
- F2Stock options granted to CytRx directors are vested in full and exercisable immediately upon issuance.